Senior biopharma journalist at Endpoints News
London
Joined November 2012
- Tweets827
- Following287
- Followers1.7K
- Likes16
⚡️BREAKING: Novo Nordisk $NVO confirms that it has stopped the HERMES and ATHENA trials of its IL-6 heart drug ziltivekimab for futility: endpoints.news/novo-nordisk-…
Elizabeth Cairns retweeted
Levin: Nobody wants this
Reuters: Nobody wanted it
Great conversation yesterday with @jmaxlevin about the $AZN $BMY maybe-deal:
youtube.com/live/NmxJ-pKWODQ
Elizabeth Cairns retweeted
Eli Lilly and Novo Nordisk's Q2 prints were quite different
the Indianapolis giant once again ballooned full-year guidance. Its Danish rival's CEO had blunt words about failure and setback, as @ByLizC notes in @endpts:
endpoints.news/novo-nordisk-…
Elizabeth Cairns retweeted
I can't wait for this: @brindaadhikari, of @WSITYpod fame, joins @ArmstrongDrew and I on a Post-Hoc Live tomorrow to talk about the new CDC pick. Brinda was also my boss at the @CBSEveningNews during the Covid-19 pandemic. A full circle moment. endpoints.news/post-hoc-live…
Elizabeth Cairns retweeted
🎙️ Today at 11am ET -- we're going to be talking MAHA, the new @CDCgov director and what it means for vaccine politics and policy. I'm super excited to be joined by @WSITYpod host Brinda Adhikari and our own Man on MAHA @maxonwifi. Link in 🧵
Elizabeth Cairns retweeted
A really cool Post-Hoc Live today, as @ArmstrongDrew and I talk with former Republican Texas Rep. @michaelcburgess.
We'll talk vaccine politics and MAHA's influence on US health policy. Before retiring in 2025, Burgess chaired the House Rules committee. endpoints.news/post-hoc-live…
Elizabeth Cairns retweeted
👎👍We're just a hours out from the release of the @endpts 2025 winners + losers list. I've got props, I've used our entire emoji quota for the year (and next), and i've included all the tweets i couldn't send.
Tune in at 12pm ET today:
endpoints.news/post-hoc-live…
Elizabeth Cairns retweeted
Exclusive: Inside Metsera as Pfizer and Novo battled for obesity’s next big prize — a high-stakes story of rivalries billion-dollar bids, and a half-finished haircut. By Drew Armstrong @ArmstrongDrew, Elizabeth Cairns @ByLizC and Kyle LaHucik @ky_lahucik. endpoints.news/exclusive-the…
Elizabeth Cairns retweeted
The new boss at Novo is doing stuff the old boss wouldn't.
Including going head-to-head against Pfizer over a big deal in obesity.
Must-read context on today's big news from @ByLizC
endpoints.news/novo-nordisks…
$NVO has doubled down on MASH with a $4.7B deal for $AKRO. My quick take for @endpts: endpoints.news/novo-nordisk-…
Elizabeth Cairns retweeted
I'll be speaking live with @vijaypande about AI in bio.
Pande left @a16z this summer after over a decade at the VC firm. He had founded bio/health practice, and we'll talk about his new AI firm: @VZVCfund
endpoints.news/post-hoc-live…
Elizabeth Cairns retweeted
TODAY at 11:30am ET, Adm. Brett Giroir joins Post-Hoc Live to talk to @ArmstrongDrew and I about the US' exiling of mRNA research. Giroir was the Assistant Secretary for Health in Trump 1.0, and worked at DARPA earlier in his career. endpoints.news/endpoints-liv…
In light of $LLY's orforglipron disappointment, I had a look at the other pills in development for obesity:
endpoints.news/obesity-pill-…
Eli Lilly’s obesity pill is less effective than Novo Nordisk’s, pivotal data suggest - endpoints.news/eli-lillys-ob…
Elizabeth Cairns retweeted
🎙️ Today on Endpoints News Post-Hoc Live, we're talking about @Sarepta. I'll be joined at 1:30pm by @Jared_Whitlock and @leilei_wuu about the company's showdown with the FDA over its hashtag #duchenne gene therapy + what comes next
endpoints.news/endpoints-liv…
Summit says PD-1xVEGF bispecific ivonsecimab misses overall survival in closely-watched lung cancer study $SMMT
endpts.com/summit-says-bispe…
Elizabeth Cairns retweeted
Live today at 3 p.m. ET: Is biotech sentiment really as bad as it seems? Join Endpoints' @JohnCendpts, @ArmstrongDrew, and @ky_lahucik for a deep dive into the latest Endpoints 100 survey. endpts.com/endpoints-livestr…
Elizabeth Cairns retweeted
🎙️Let's talk "most favored nation"!
Today on Post-Hoc Live, I'll be joined by biotech lobbyist Nick Shipley to unpack the last 24 hours of Trump's drug pricing exec order, how it would work (or not), unintended consequences + what happens next. Join us!
endpts.com/endpoints-livestr…
$LLY's oral GLP-1 looks good in diabetes, but the real test is the upcoming obesity readout. Nice piece from @MaxGelman here:
endpts.com/eli-lilly-reports…
$PFE has dropped its obesity pill danuglipron:
endpts.com/in-a-blow-to-its-…
